GSA CAPITAL PARTNERS LLP - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 60 filers reported holding CONATUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$114,000
+123.5%
19,721
+65.0%
0.01%
+100.0%
Q2 2018$51,000
-12.1%
11,950
+17.7%
0.00%
-25.0%
Q2 2017$58,00010,1500.00%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
JBF Capital, Inc. 520,553$161,0000.03%
Kalos Management, Inc. 43,940$13,0000.01%
ACADIAN ASSET MANAGEMENT LLC 1,351,000$419,0000.00%
Quilter Plc 60,546$19,0000.00%
ALBION FINANCIAL GROUP /UT 12,000$4,0000.00%
REILLY FINANCIAL ADVISORS, LLC 22,011$7,0000.00%
MORGAN STANLEY 1,900$1,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 24,900$8,0000.00%
BlackRock Inc. 645,611$200,0000.00%
Bank of New York Mellon Corp 137,500$43,0000.00%
View complete list of CONATUS PHARMACEUTICALS INC shareholders